【正文】
趙久良 北京協(xié)和醫(yī)院風(fēng)濕(fēnɡ shī)免疫科,免疫抑制劑的臨床(l237。n chu225。nɡ)應(yīng)用,第一頁,共四十頁。,Immunosuppressive drugs,dampen the immune system—notably T and B lymphocytes—functionally and/or numerically but do not permanently correct the fundamental imbalance of immune regulation in autoimmune disease.,第二頁,共四十頁。,免疫(miǎny236。)抑制劑的共性,Effective and indispensable as remissioninducing and maintenance agents in the management of inflammatory rheumatic conditions. Constitute a heterogeneous group of compounds, each with a unique mode of action and toxicity profile. Associated with an increased risk of bacterial, viral, and fungal infection,第三頁,共四十頁。,6硫嘌呤(pi224。ol236。ng) 6硫鳥嘌呤 抑制嘌呤合成,甲氨蝶呤 抑制(y236。zh236。)嘌呤合成 抑制dTMP合成,阿糖胞苷 抑制(y236。zh236。)DNA合成酶,三尖杉酯堿 抑制蛋白合成,L門冬酰氨酶 抑制蛋白合成,5氟胞嘧啶 抑制dTMP合成,博萊霉素 損傷DNA及阻礙修復(fù),烷化劑,順鉑,絲裂霉素 與DNA交叉聯(lián)合,柔紅霉素,依托泊苷,安吖啶 抑制DNA合成,放線菌D 嵌入DNA,抑制RNA合成,長春新堿 抑制微管功能,激素類,第四頁,共四十頁。,硫唑嘌呤 抑制(y236。zh236。)嘌呤合成,甲氨蝶呤 抑制嘌呤(pi224。ol236。ng)合成 抑制dTMP合成,來氟米特 抑制(y236。zh236。)dTMP合成,環(huán)磷酰胺 與DNA交叉聯(lián)合,激素類 抑制炎癥因子,霉酚酸酯 阻斷嘌呤合成,鈣調(diào)蛋白抑制劑 損傷DNA及阻礙修復(fù),第五頁,共四十頁。,環(huán)磷酰胺CYC,第六頁,共四十頁。,環(huán)磷酰胺CYC,機制:烷化劑,細(xì)胞周期非特異性細(xì)胞毒藥物 減少T及B細(xì)胞數(shù),抑制細(xì)胞分化及增殖